Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.30    -0.50 (-27.78%)
Bid:
1.30
Ask:
2.02
Spread: 0.72 (55.385%)
Market Cap: £4.56m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Directorate Change

23 Dec 2009 15:55

RNS Number : 6704E
Proteome Sciences PLC
23 December 2009
 



Proteome Sciences plc 

("Proteome Sciences" or "the Company")

Resignation of Director 

and 

Appointment of Chief Operating Officer

23rd December 2009: The Board of Proteome Sciences announces that Dr. Peter Schulz-Knappe will be leaving Proteome Sciences R&D GmbH & Co. KG on 31st December 2009 in order to be based more closely to his family, at which point he will resign as a director from the Company. The directors would like to thank Dr. Schulz-Knappe for his considerable contribution to the Company's progress and wish him every success in the future.

The Company is pleased to announce that Dr. Ian Pike has been appointed Chief Operating Officer of the Company and its subsidiaries and that Dr. Hans-Dieter Zucht has been appointed as Chief Technical Officer of Proteome Sciences R&D GmbH Co. KG in Frankfurt. Neither of these are appointments to the board of Proteome Sciences.

Ends

For further information please contact: 

Proteome Sciences plc

www.proteomics.com

Tel: +44 (0)1932 865065

Christopher Pearce, Chief Executive

James Malthouse, Finance Director 

Dr. Ian Pike, Chief Operating Officer

Email: christopher.pearce@proteomics.com

Email: james.malthouse@proteomics.com

Email: ian.pike@proteomics.com

Public Relations

IKON Associates 

Adrian Shaw

Tel: +44 (0)1483 271291

Mobile: +44 (0)797 9900733

Email: adrian@ikonassociates.com

Redleaf Communications Ltd. 

Samantha Robbins / Anna Dunkin 

Tel: +44 (0)20 7566 6700

Email: proteome@redleafpr.com

Nominated Adviser

Noble & Company Ltd.

John Llewellyn-Lloyd

Tel: +44 (0)20 7763 2200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEXLFLKLBEFBZ
Date   Source Headline
3rd Aug 20227:00 amRNSMilestone towards Single Cell Proteomics services
26th May 20229:04 amRNSChange of Registered Office
16th May 20221:24 pmRNSResult of AGM
16th May 20227:00 amRNSAGM Statement
12th May 20227:00 amRNSSubstantial Contract Win
26th Apr 20224:45 pmRNSDirector/PDMR Shareholding
21st Apr 20225:13 pmRNSDirector/PDMR Shareholding
11th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20226:01 pmRNSDirector shareholding
31st Mar 20227:09 amRNSFinal Results
30th Mar 202211:24 amRNSLoan amendment
29th Mar 20227:00 amRNSNotice of Results
16th Feb 20224:40 pmRNSSecond Price Monitoring Extn
16th Feb 20224:35 pmRNSPrice Monitoring Extension
3rd Feb 20227:00 amRNSTrading Update
31st Dec 202112:36 pmRNSPrice Monitoring Extension
20th Dec 20217:00 amRNSSubstantial Contract Win
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
29th Nov 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20214:36 pmRNSPrice Monitoring Extension
5th Nov 20217:00 amRNSPRM,INmune Bio presenting biomarker discovery data
3rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:36 pmRNSPrice Monitoring Extension
26th Aug 20214:40 pmRNSSecond Price Monitoring Extn
26th Aug 20214:36 pmRNSPrice Monitoring Extension
29th Jul 20217:00 amRNSInterim Results
15th Jul 20214:41 pmRNSSecond Price Monitoring Extn
15th Jul 20214:35 pmRNSPrice Monitoring Extension
18th Jun 20211:14 pmRNSLoan amendment
8th Jun 202112:54 pmRNSGrant of Options and PDMR/director shareholdings
19th May 20216:01 pmRNSIssuance of key TMT Patent
18th May 20219:48 amRNSChange of Registered Office
12th May 20214:36 pmRNSPrice Monitoring Extension
7th May 20214:41 pmRNSSecond Price Monitoring Extn
7th May 20214:36 pmRNSPrice Monitoring Extension
6th May 20214:41 pmRNSSecond Price Monitoring Extn
6th May 20214:35 pmRNSPrice Monitoring Extension
5th May 20214:41 pmRNSSecond Price Monitoring Extn
5th May 20214:35 pmRNSPrice Monitoring Extension
5th May 202111:57 amRNSResult of AGM
5th May 202111:00 amRNSAGM Statement
27th Apr 20214:40 pmRNSSecond Price Monitoring Extn
27th Apr 20214:35 pmRNSPrice Monitoring Extension
19th Apr 20215:25 pmRNSDirector/PDMR Shareholding
14th Apr 202112:18 pmRNSDirector/PDMR Shareholding
7th Apr 20214:40 pmRNSSecond Price Monitoring Extn
7th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:48 pmRNSHolding(s) in Company
1st Apr 20219:34 amRNSInvestor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.